Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1024

1.

Somatic aberrations of mismatch repair genes as a cause of microsatellite-unstable cancers.

Geurts-Giele WR, Leenen CH, Dubbink HJ, Meijssen IC, Post E, Sleddens HF, Kuipers EJ, Goverde A, van den Ouweland AM, van Lier MG, Steyerberg EW, van Leerdam ME, Wagner A, Dinjens WN.

J Pathol. 2014 Dec;234(4):548-59. doi: 10.1002/path.4419. Epub 2014 Sep 30.

PMID:
25111426
[PubMed - indexed for MEDLINE]
2.

MLH1 and MSH2 mutation screening in HNPCC families of Hungary - Two new MMR gene mutations.

Tanyi M, Olasz J, Tanyi JL, Tóth L, Antal-Szalmás P, Ress Z, Bubán T, Palatka K, András C, Urbancsek H, Garami Z, Csuka O, Damjanovich L.

Eur J Surg Oncol. 2014 Nov;40(11):1445-52. doi: 10.1016/j.ejso.2014.07.032. Epub 2014 Jul 24.

PMID:
25107687
[PubMed - indexed for MEDLINE]
3.

BRAF mutation analysis is a valid tool to implement in Lynch syndrome diagnosis in patients classified according to the Bethesda guidelines.

Molinari F, Signoroni S, Lampis A, Bertan C, Perrone F, Sala P, Mondini P, Crippa S, Bertario L, Frattini M.

Tumori. 2014 May-Jun;100(3):315-20. doi: 10.1700/1578.17214.

PMID:
25076244
[PubMed - indexed for MEDLINE]
4.

Immunohistochemistry versus next-generation sequencing for the routine detection of BRAF V600E mutation in melanomas.

Just PA, Audebourg A, Pasmant E, Clauser E, Carlotti A, Laurent S, Avril MF, Vacher-Lavenu MC, Vidaud M, Terris B.

Hum Pathol. 2014 Sep;45(9):1983-4. doi: 10.1016/j.humpath.2014.05.017. Epub 2014 Jun 18. No abstract available.

PMID:
25074543
[PubMed - indexed for MEDLINE]
5.

Prevalence of germline MUTYH mutations among Lynch-like syndrome patients.

Castillejo A, Vargas G, Castillejo MI, Navarro M, Barberá VM, González S, Hernández-Illán E, Brunet J, Ramón y Cajal T, Balmaña J, Oltra S, Iglesias S, Velasco A, Solanes A, Campos O, Sánchez Heras AB, Gallego J, Carrasco E, González Juan D, Segura A, Chirivella I, Juan MJ, Tena I, Lázaro C, Blanco I, Pineda M, Capellá G, Soto JL.

Eur J Cancer. 2014 Sep;50(13):2241-50. doi: 10.1016/j.ejca.2014.05.022. Epub 2014 Jun 18.

PMID:
24953332
[PubMed - indexed for MEDLINE]
6.

Role of the clinical pathology laboratory in the evaluation of endometrial carcinomas for Lynch syndrome.

Djordjevic B, Broaddus RR.

Semin Diagn Pathol. 2014 May;31(3):195-204. doi: 10.1053/j.semdp.2014.03.005. Epub 2014 Apr 2. Review.

PMID:
24951283
[PubMed - indexed for MEDLINE]
7.

Germline mutation of RPS20, encoding a ribosomal protein, causes predisposition to hereditary nonpolyposis colorectal carcinoma without DNA mismatch repair deficiency.

Nieminen TT, O'Donohue MF, Wu Y, Lohi H, Scherer SW, Paterson AD, Ellonen P, Abdel-Rahman WM, Valo S, Mecklin JP, Järvinen HJ, Gleizes PE, Peltomäki P.

Gastroenterology. 2014 Sep;147(3):595-598.e5. doi: 10.1053/j.gastro.2014.06.009. Epub 2014 Jun 15.

PMID:
24941021
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Loss of heterozygosity and microsatellite instability are rare in sporadic dedifferentiated liposarcoma: a study of 43 well-characterized cases.

Davis JL, Grenert JP, Horvai AE.

Arch Pathol Lab Med. 2014 Jun;138(6):823-7. doi: 10.5858/arpa.2013-0236-OA.

PMID:
24878023
[PubMed - indexed for MEDLINE]
9.

Comprehensive molecular characterisation of hereditary non-polyposis colorectal tumours with mismatch repair proficiency.

Bellido F, Pineda M, Sanz-Pamplona R, Navarro M, Nadal M, Lázaro C, Blanco I, Moreno V, Capellá G, Valle L.

Eur J Cancer. 2014 Jul;50(11):1964-72. doi: 10.1016/j.ejca.2014.04.022. Epub 2014 May 16.

PMID:
24841217
[PubMed - indexed for MEDLINE]
10.

Microsatellite testing in colon cancer.

Mahon SM.

Oncol Nurs Forum. 2014 May;41(3):331-3. doi: 10.1188/14.ONF.331-333.

PMID:
24769599
[PubMed - indexed for MEDLINE]
11.

Mismatch repair protein immunohistochemistry: a useful population screening strategy for Lynch syndrome.

Musulén E, Sanz C, Muñoz-Mármol AM, Ariza A.

Hum Pathol. 2014 Jul;45(7):1388-96. doi: 10.1016/j.humpath.2014.02.012. Epub 2014 Feb 26.

PMID:
24768606
[PubMed - indexed for MEDLINE]
12.

Systematic study on genetic and epimutational profile of a cohort of Amsterdam criteria-defined Lynch Syndrome in Singapore.

Liu Y, Chew MH, Goh XW, Tan SY, Loi CT, Tan YM, Law HY, Koh PK, Tang CL.

PLoS One. 2014 Apr 7;9(4):e94170. doi: 10.1371/journal.pone.0094170. eCollection 2014.

PMID:
24710284
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Genetic mechanisms in interval colon cancers.

Richter JM, Pino MS, Austin TR, Campbell E, Szymonifka J, Russo AL, Hong TS, Borger D, Iafrate AJ, Chung DC.

Dig Dis Sci. 2014 Sep;59(9):2255-63. doi: 10.1007/s10620-014-3134-2. Epub 2014 Apr 5.

PMID:
24705641
[PubMed - indexed for MEDLINE]
14.

Immunohistochemical expression pattern of MMR protein can specifically identify patients with colorectal cancer microsatellite instability.

Amira AT, Mouna T, Ahlem B, Raoudha A, Majid BH, Amel H, Rachida Z, Nadia K.

Tumour Biol. 2014 Jul;35(7):6283-91. doi: 10.1007/s13277-014-1831-2. Epub 2014 Mar 19.

PMID:
24643686
[PubMed - indexed for MEDLINE]
15.

[Should we systematically screen for Lynch syndrome in patients with upper urinary tract carcinoma?].

Olagui GS, Pignot G, Rouquette A, Vieillefond A, Amsellem-Ouazana D, de Longchamps NB, Radenen B, Zerbib M, Terris B.

Bull Cancer. 2014 Feb;101(2):144-50. doi: 10.1684/bdc.2014.1896. French.

PMID:
24556207
[PubMed - indexed for MEDLINE]
16.

Immunohistochemical detection of BRAF V600E mutant protein using the VE1 antibody in colorectal carcinoma is highly concordant with molecular testing but requires rigorous antibody optimization.

Kuan SF, Navina S, Cressman KL, Pai RK.

Hum Pathol. 2014 Mar;45(3):464-72. doi: 10.1016/j.humpath.2013.10.026. Epub 2013 Nov 4.

PMID:
24529329
[PubMed - indexed for MEDLINE]
17.

Pyloric gland adenoma in Lynch syndrome.

Lee SE, Kang SY, Cho J, Lee B, Chang DK, Woo H, Kim JW, Park HY, Do IG, Kim YE, Kushima R, Lauwers GY, Park CK, Kim KM.

Am J Surg Pathol. 2014 Jun;38(6):784-92. doi: 10.1097/PAS.0000000000000185.

PMID:
24518125
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Functional analysis of MSH2 unclassified variants found in suspected Lynch syndrome patients reveals pathogenicity due to attenuated mismatch repair.

Wielders EA, Hettinger J, Dekker R, Kets CM, Ligtenberg MJ, Mensenkamp AR, van den Ouweland AM, Prins J, Wagner A, Dinjens WN, Dubbink HJ, van Hest LP, Menko F, Hogervorst F, Verhoef S, te Riele H.

J Med Genet. 2014 Apr;51(4):245-53. doi: 10.1136/jmedgenet-2013-101987. Epub 2014 Feb 5.

PMID:
24501230
[PubMed - indexed for MEDLINE]
19.

Population-based screening for Lynch syndrome in Western Australia.

Schofield L, Grieu F, Amanuel B, Carrello A, Spagnolo D, Kiraly C, Pachter N, Goldblatt J, Platell C, Levitt M, Stewart C, Salama P, Ee H, Raftopoulous S, Katris P, Threlfall T, Edkins E, Wallace M, Iacopetta B.

Int J Cancer. 2014 Sep 1;135(5):1085-91. doi: 10.1002/ijc.28744. Epub 2014 Feb 24.

PMID:
24474394
[PubMed - indexed for MEDLINE]
20.

Muir-Torre syndrome: case report and molecular characterization.

Rios CA, Villalón R, Muñoz J, Acuña M, Cifuentes L.

Sao Paulo Med J. 2014;132(1):61-4. doi: 10.1590/1516-3180.2014.1321634.

PMID:
24474082
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk